A Study of BR111 in Patients With Advanced Malignancies

NCT06937957 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancies

Interventions

DRUG: BR111 for Injection
DRUG: BR111 for Injection

Sponsor

BioRay Pharmaceutical Co., Ltd.